A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen

A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen

Prognosis for diffuse intrinsic pontine glioma (DIPG) and generally for diffuse midline gliomas (DMG) has only marginally improved over the last ~40 years despite dozens of chemotherapy and other therapeutic trials. The prognosis remains invariably fatal. We present here the rationale for a planned...

Full description

Bibliographic Details
Main Authors:	Richard E. Kast, Alex P. Michael, Iacopo Sardi, Terry C. Burns, Tim Heiland, Georg Karpel-Massler, Francois G. Kamar, Marc-Eric Halatsch
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Brain Sciences
Subjects:	5-aminolevulinic acid diffuse intrinsic pontine glioma diffuse midline gliomas fluorescence glioblastoma irradiation photodynamic prognosis protoporphyrin ix reactive oxygen species
Online Access:	https://www.mdpi.com/2076-3425/10/1/51

Similar Items

The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence
by: Sergey A. Goryaynov, et al.
Published: (2019-05-01)

A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report
by: Kristof Babarczy, et al.
Published: (2021-01-01)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
by: Valentina Di Ruscio, et al.
Published: (2022-08-01)

Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
by: Xin Wei, et al.
Published: (2021-08-01)

Comprehensive profiling of stem-like features in pediatric glioma cell cultures and their relation to the subventricular zone
by: Marc-Antoine Da-Veiga, et al.
Published: (2023-06-01)

Diffuse Midline Gliomas: Challenges and New Strategies in a Changing Clinical Landscape
by: Umberto Tosi, et al.
Published: (2024-01-01)

Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
by: Andrew Groves, et al.
Published: (2022-12-01)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
by: Davis P. Argersinger, et al.
Published: (2021-10-01)

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
by: Tina Y. Huang, et al.
Published: (2017-04-01)

A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma
by: Jacqueline P. Whitehouse, et al.
Published: (2020-10-01)

Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma
by: Casper J. Pachocki, et al.
Published: (2022-11-01)

Convection Enhanced Delivery for Diffuse Intrinsic Pontine Glioma: Review of a Single Institution Experience
by: Umberto Tosi, et al.
Published: (2020-07-01)

Evaluating drug distribution in children and young adults with diffuse midline glioma of the pons (DIPG) treated with convection-enhanced drug delivery
by: Elwira Szychot, et al.
Published: (2023-02-01)

Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives
by: Marc-Antoine Da-Veiga, et al.
Published: (2022-05-01)

The promise of metabolic imaging in diffuse midline glioma
by: Samantha Lovibond, et al.
Published: (2023-05-01)

H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes
by: Charles A. Day, et al.
Published: (2022-10-01)

Enhancement of 5-aminolevulinic acid-induced photodynamic therapy by a bioadhesive polymer
by: Shu-Fang Chang, et al.
Published: (2010-03-01)

Clinical Presentation, MRI findings and Molecular insights in Diffuse Intrinsic Pontine Gliomas (DIPGs): A Comprehensive Review.
by: Gustavo Novelino Simao
Published: (2023-09-01)

Systematic Review and Meta-Analysis of In Vitro Anti-Human Cancer Experiments Investigating the Use of 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy
by: Yo Shinoda, et al.
Published: (2021-03-01)

Interdisciplinary care of children with diffuse midline glioma
by: Christina Coleman, et al.
Published: (2023-01-01)

Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
by: Elisha Hayden, et al.
Published: (2021-12-01)

Childhood brainstem gliomas: A non-aggressive management
by: Nourou Dine Adeniran Bankole, MD, et al.
Published: (2022-06-01)

5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges
by: Yoshinori Harada, et al.
Published: (2022-06-01)

Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas
by: Jeffrey I. Traylor, et al.
Published: (2021-02-01)

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
by: Niklas Grassl, et al.
Published: (2023-10-01)

Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies
by: Waleed M. Kholosy, et al.
Published: (2021-08-01)

Effect of 5-aminolevulinic Acid on Mitochondrial Activity
by: Yuliya V. Markina, et al.
Published: (2023-12-01)

5-Aminolevulinic acid: A matter of life and caveats
by: Etelvino J.H. Bechara, et al.
Published: (2021-09-01)

5-ALA induced PpIX fluorescence spectroscopy in neurosurgery: a review
by: A. Gautheron, et al.
Published: (2024-01-01)

Enlarging the Scope of 5-Aminolevulinic Acid-Mediated Photodiagnosis towards Breast Cancers
by: Martin Kiening, et al.
Published: (2022-11-01)

Efficacy of 5-Aminolevulinic Acid in Photodynamic Detection and Photodynamic Therapy in Veterinary Medicine
by: Tomohiro Osaki, et al.
Published: (2019-04-01)

Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord
by: Quanquan Gu, et al.
Published: (2021-12-01)

The Role of Reirradiation in Childhood Progressive Diffuse Intrinsic Pontine Glioma (DIPG): An Ongoing Challenge beyond Radiobiology
by: Maria Chiara Lo Greco, et al.
Published: (2023-10-01)

Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry
by: Hunter C. Gits, et al.
Published: (2018-07-01)

Imaging characterization of an adult H3 K27M-altered diffuse midline glioma of the medulla oblongata with a confounding steroid response
by: Claudia Godi, MD, et al.
Published: (2023-03-01)

Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease
by: J. Qi, et al.
Published: (2019-05-01)

Delta-Aminolevulinic Acid-Mediated Photodiagnoses in Surgical Oncology: A Historical Review of Clinical Trials
by: Joseph F. Georges, et al.
Published: (2019-09-01)

Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project
by: Lara Chavaz, et al.
Published: (2022-06-01)

Erratum: Neurological symptom improvement after re-irradiation in patients with diffuse intrinsic pontine glioma: A retrospective analysis of the SIOP-E-HGG/DIPG project
by: Frontiers Production Office
Published: (2023-03-01)

LIN28B and Let-7 in Diffuse Midline Glioma: A Review
by: Truman Knowles, et al.
Published: (2023-06-01)